nimustine has been researched along with Waldenstrom Macroglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, Y; Furukawa, K; Hirota, Y; Nakaide, Y; Tanaka, M | 1 |
| Maruo, K; Nagata, K; Yoshikawa, H | 1 |
2 other study(ies) available for nimustine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
[Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
Topics: Aged; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nimustine; Nitrosourea Compounds; Prednisolone; Procarbazine; Vincristine; Waldenstrom Macroglobulinemia | 1980 |
[A case report of macroglobulinemia responded to AAAP-therapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Nimustine; Nitrosourea Compounds; Prednisolone; Waldenstrom Macroglobulinemia | 1982 |